Showing 1 - 15 results of 15 for search 'Sande, C', query time: 1.01s
Refine Results
-
1
RSV vaccine use - the missing data by Drysdale, S, Sande, C, Green, C, Pollard, A
Published 2015Journal article -
2
Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations by Drysdale, S, Barr, R, Green, C, Pollard, A, Sande, C
Published 2020Journal article -
3
Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics by Sande, C, Mutunga, M, Muteti, J, Berkley, J, Nokes, D, Njunge, J
Published 2018Journal article -
4
-
5
-
6
Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection by Gerretsen, H, Capone, S, Vitelli, A, Reyes, L, Thompson, A, Jones, C, Green, C, Pollard, A, Sande, C
Published 2018Journal article -
7
-
8
Non-specific immunological effects of selected routine childhood immunisations: systematic review by Kandasamy, R, Voysey, M, McQuaid, F, de Nie, K, Ryan, R, Orr, O, Uhlig, U, Sande, C, O'Connor, D, Pollard, A
Published 2016Journal article -
9
Humoral and cellular immunity to RSV in infants, children and adults by Green, C, Sande, C, De Lara, C, Thompson, A, Silva-Reyes, L, Napolitano, F, Pierantoni, A, Capone, S, Vitelli, A, Klenerman, P, Pollard, A
Published 2018Journal article -
10
Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England... by Zylbersztejn, A, Pembrey, L, Goldstein, H, Berbers, G, Schepp, R, van der Klis, F, Sande, C, Mason, D, Wright, J, Smyth, R, Hardelid, P
Published 2021Journal article -
11
Airway response to respiratory syncytial virus has incidental antibacterial effects by Sande, C, Njunge, J, Ngoi, J, Mutunga, M, Chege, T, Gicheru, E, Gardiner, E, Gwela, A, Green, C, Drysdale, S, Berkley, J, Nokes, D, Pollard, A
Published 2019Journal article -
12
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-R... by Green, C, Scarselli, E, Voysey, M, Capone, S, Vitelli, A, Nicosia, A, Cortese, R, Thompson, A, Sande, C, de Lara, C, Klenerman, P, Pollard, A
Published 2015Journal article -
13
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults by Green, C, Sande, C, Scarselli, E, Capone, S, Vitelli, A, Nicosia, A, Silva-Reyes, L, Thompson, A, De Lara, C, Taylor, K, Haworth, K, Hutchings, C, Cargill, T, Angus, B, Klenerman, P, Pollard, A
Published 2019Journal article -
14
Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults by Green, C, McGinley, J, Sande, C, Capone, S, Makvandi-Nejad, S, Vitelli, A, Silva-Reyes, L, Bibi, S, Otasowie, C, Sheerin, D, Thompson, A, Dold, C, Klenerman, P, Barnes, E, Dorrell, L, Rollier, C, Pollard, A, O'Connor, D
Published 2023Journal article -
15
Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults. by Green, C, Scarselli, E, Sande, C, Thompson, A, de Lara, C, Taylor, K, Haworth, K, Del Sorbo, M, Angus, B, Siani, L, Di Marco, S, Traboni, C, Folgori, A, Colloca, S, Capone, S, Vitelli, A, Cortese, R, Klenerman, P, Nicosia, A, Pollard, A
Published 2015Journal article